MJ Kievman, Founder and CEO

Colby College

The patient-founder of Meter Health, MJ leads a team of world-class biotechnology executives while driving corporate strategy and fundraising activities. A patented inventor, she is also active in Meter’s scientific publications and clinical research.

Bart LinkedIn pic

Bartholomew Bacak, MD, PhD.

Scientific Co-Founder Drexel Univ. and Univ. of Rochester

A leading researcher on the hiccups and physician at University of Rochester (NY). Bart’s mathematical modeling work in a neuro-respiratory lab formed the basis for an advanced understanding of the underlying science and evolutionary nature of the hiccups.

Heidi L. Wagner, JD, COO

Genentech, Alexion, Global Blood Therapeutics

Heidi’s leadership experience spans pricing and reimbursement, payer strategy, government affairs, and patient advocacy. Her prior executive-level experience from Genentech, Alexion, and Global Blood Therapeutics is complemented by publicly-traded board appointments.

Bob Cooper, MBA, CCO

Ceiba, iQuest, Bomber Ski, Kodak

A seasoned C-suite executive, Bob‘s leadership, sales, and marketing experience crosses global consumer products (Bomber Ski, Hastens) to healthcare data and analytics (iQuest, Ceiba).

Andrew photo

Andrew Robinson, RPh, Executive Vice President- Supply Chain

CVS, SpecialtyScripts

A pharmacist by training, Andrew left CVS in 2003 to start SpecialtyScripts, a specialty pharmacy. Andrew grew the company from a startup to having $250 million in annual sales and an exit to Cardinal Health and Walgreens.

Dave Wilson Head Shot

Dave Wilson, Chief Strategy Officer

Genzyme, Quintiles, PPD

Bringing 30+ years in biopharma, CROs, and medical devices, Dave has experience overseeing programs to support value messages across stakeholder groups for rare disease therapeutics. His previous roles include leadership positions at Genzyme, Quintiles, and PPD.

Adam profile pic square

Adam Kievman, Executive Chairman

Alexion, Alnylam, Moderna

With 25 years of experience building leadership teams and scaling top biopharma and VC-backed biotech companies, Adam’s executive-level experience includes Alexion, Moderna, and Alnylam.